LY4086940
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
Eli Lilly · Phase 2 · Not yet recruiting · Enrollment 460
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| LY4086940 Dose 1 | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 2 | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 3, Titration Schedule A | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 3, Titration Schedule B | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 4 | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 5 | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule A | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule B | n/r | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule C | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.